MktsMarkets

iBio, Inc.
NASDAQ: IBIOKey statistics
IBIO News
Stories mentioning IBIO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 100.00 | 200.00 | 0.00 | 200.00 | 0.00 | ||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | |||||||
| Operating Expenses | ||||||||
| Research & Development | 3,254 | 4,280 | 3,550 | 3,224 | 1,906 | 1,877 | 1,305 | 1,140 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 8,365 | 9,445 | 6,051 | 5,398 | 4,879 | 4,619 | 4,106 | 3,584 |
| Operating Income (Loss) | (8,365) | (9,445) | (5,951) | (5,198) | (4,879) | (4,419) | (4,106) | (3,409) |
| Interest Income | 657.00 | 493.00 | 267.00 | 79.00 | 72.00 | 112.00 | 174.00 | 223.00 |
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income (Loss) | (7,730) | (8,993) | (5,720) | (5,163) | (4,861) | (4,364) | (3,989) | (7,778) |
| Earnings Per Share (Basic) | (0.06) | (0.09) | (0.11) | (0.49) | (0.49) | (0.48) | (0.46) | (2.03) |
| Earnings Per Share (Diluted) | (0.06) | (0.09) | (0.11) | (0.49) | (0.49) | (0.48) | (0.46) | (2.03) |
| Weighted Average Shares Outstanding (Basic) | 119,600 | 99,133 | 52,981 | 10,499 | 9,862 | 9,132 | 8,633 | 3,831 |
| Weighted Average Shares Outstanding (Diluted) | 119,600 | 99,133 | 52,981 | 10,499 | 9,862 | 9,132 | 8,633 | 3,831 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About IBIO
iBio, Inc. (NASDAQ: IBIO) is a stock listed on the Nasdaq Stock Market under the ticker symbol IBIO. It last traded at $0.7300 (Nov 13, 2026, 4:00 PM ET), down 4.0% on the day. That gives iBio a market capitalisation of $51.6M.
Over the past 52 weeks IBIO has traded between $0.6900 and $3.82.
For the quarter ended Mar 31, 2026 it reported a net loss of $7.7M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | — | -$7.7M | — |
| Dec 31, 2025 | $0 | -$9.0M | — |
| Sep 30, 2025 | $100.0K | -$5.7M | -5720.0% |
| Jun 30, 2025 | $200.0K | -$5.2M | -2581.5% |
From iBio’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…